<unk>  is highly effective in the treatment of chronic lymphocytic leukemia, producing higher response rates than alkylating agents such as chlorambucil alone.<unk>  is used in various combinations with cyclophosphamide, mitoxantrone, dexamethasone and rituximab in the treatment of indolent non-Hodgkin's lymphomas. As part of the FLAG or FLAMSA regimen,<unk>  is used together with cytarabine and granulocyte colony-stimulating factor in the treatment of acute myeloid leukaemia. Because of its immunosuppressive effects,<unk>  is also used in some conditioning regimens prior to allogeneic stem cell transplant.
Fludarabine
Clofarabine
Nelarabine
Cladribine
Cytarabine
Vincristine
Ifosfamide
Lenalidomide